Skip to main content

and
  1. Article

    Open Access

    Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report

    Pembrolizumab (PEM), an immune checkpoint inhibitor (ICI), is often used for triple-negative breast cancer, but can also be used to treat solid tumors that exhibit high microsatellite instability (MSI-High). H...

    Keiko Inakami, Noriko Fujita, Chikage Iguchi in Journal of Medical Case Reports (2024)

  2. Article

    Open Access

    “Staying at home” to tackle COVID-19 pandemic: rhetoric or reality? Cross-cutting analysis of nine population groups vulnerable to homelessness in Japan

    Although the “stay-at-home” order is advocated against the coronavirus disease 2019 (COVID-19), the lives of individuals lacking adequate housing are threatened. We developed a framework to assess various popu...

    Masami Fujita, Sadatoshi Matsuoka, Hiroyuki Kiyohara in Tropical Medicine and Health (2020)